As such, Harz et al. [79] evaluated the ability of TXNDC16 antigens as meningioma specific biomarkers by assessing 163 TXDNC16 peptide arrays to identify specific TXNDC16 epitopes exclusively recognized by meningioma autoantibodies. This evidence concerns the gene TXNDC16 and meningioma.